Silexion Therapeutics LTD (SLXNW)
0.05
-0.00 (-0.99%)
At close: Apr 16, 2025, 3:58 PM
-0.99% (1D)
| Bid | 0.05 |
| Market Cap | 6.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.05 |
| Volume | 23,478 |
| Avg. Volume (20D) | 37,248.637 |
| Open | 0.05 |
| Previous Close | 0.05 |
| Day's Range | 0.05 - 0.06 |
| 52-Week Range | 0.05 - 0.06 |
| Beta | 0.06 |
About SLXNW
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, ...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 16, 2024
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol SLXNW
Website https://silexion.com